Regulation of cell size and contractile function by AKT in cardiomyocytes

Annals of the New York Academy of Sciences

Volumn 1015, Issue , 2004, Pages 250-260

  Latronico, Michael V G ^a   Costinean, Stefan ^b   Lavitrano, Maria Luisa ^c   Peschle, Cesare ^b,d   Condorelli, Gianluigi ^a,e  

^a S Raffaele Biomed Sci Pk of Rome   (Italy)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AKT; Heart failure; Hypertrophy; Inotropism; Signal transduction

Indexed keywords

BETA ADRENERGIC RECEPTOR; CALCIUM ION; GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; S6 KINASE; SOMATOMEDIN C;

APOPTOSIS; CELL METABOLISM; CELL SIZE; CELL SURVIVAL; CONFERENCE PAPER; DOWNSTREAM PROCESSING; ENZYME ACTIVATION; GENE OVEREXPRESSION; GLUCOSE METABOLISM; HEART FUNCTION; HEART MUSCLE CELL; HOMEOSTASIS; HUMAN; INOTROPISM; MUSCLE FIBER CONTRACTION; NONHUMAN; SIGNAL TRANSDUCTION;

EID: 3042718647     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1302.021     Document Type: Conference Paper

References (35)

1. BELLACOSA, A., J.R. TESTA, S.P. STAAL & P.N. TSICHLIS. 1991. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 254: 274-277.
2. OBATA, T., M.B. YAFFE, G.G. LEPARC, et al. 2000. Peptide and protein library screening defines optimal substrate motifs for AKT/PKB. J. Biol. Chem. 275: 36108-36115.
3. BELLACOSA, A., T.F. FRANKE, M.E. GONZALEZ-PORTAL, et al. 1993. Structure, expression and chromosomal mapping of c-akt: relationship to v-akt and its implications. Oncogene 8: 745-754.
4. DATTA, S.R., A. BRUNET & M.E. GREENBERG. 1999. Cellular survival: a play in three Akts. Genes Dev. 13: 2905-2927.
5. SABLE, C.L., N. FILIPPA, B. HEMMINGS, et al. 1997. cAMP stimulates protein kinase B in a Wortmannin-insensitive manner. FEBS Lett. 409: 253-257.
6. YANO, S., H. TOKUMITSU & T.R. SODERLING. 1998. Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway. Nature 396: 584-587.
7. HARDT, S.E. & J. SADOSHIMA. 2002. Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development. Circ. Res. 90: 1055-1063.
8. OH, H., Y. FUJIO, K. KUNISADA, et al. 1998. Activation of phosphatidylinositol 3-kinase through glycoprotein 130 induces protein kinase B and p70 S6 kinase phosphorylation in cardiac myocytes. J. Biol. Chem. 273: 9703-9710.
9. FUJIO, Y., T. NGUYEN, D. WENCKER, et al. 2000. AKT promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 101: 660-667.
10. MORISCO, C., D. ZEBROWSKI, G. CONDORELLI, et al. 2000. The Akt-glycogen synthase kinase 3beta pathway regulates transcription of atrial natriuretic factor induced by beta-adrenergic receptor stimulation in cardiac myocytes. J. Biol. Chem. 275: 14466-14475.
11. MORISCO, C., K. SETA, S.E. HARDT, et al. 2001. Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes. J. Biol. Chem. 276: 28586-28597.
12. ZHU, W.Z., M. ZHENG, W.J. KOCH, et al. 2001. Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes. Proc. Natl. Acad. Sci. USA 98: 1607-1612.
13. TANAKA, N., T. RYOKE, M. HONGO, et al. 1998. Effects of growth hormone and IGF-I on cardiac hypertrophy and gene expression in mice. Am. J. Physiol. 275: H393-H399.
14. SHIOJIMA, I., M. YEFREMASHVILI, Z. LUO, et al. 2002. Akt signaling mediates postnatal heart growth in response to insulin and nutritional status. J. Biol. Chem. 277: 37670-37677.
15. SHIOI, T., P.M. KANG, P.S. DOUGLAS, et al. 2000. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J. 19: 2537-2548.
16. CRACKOWER, M.A., G.Y. OUDIT, I. KOZIERADZKI, et al. 2002. Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell 110: 737-749.
17. NAGA PRASAD, S.V., S.A. LAPORTE, D. CHAMBERLAIN, et al. 2002. Phosphoinositide 3-kinase regulates beta2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/beta-arrestin complex. J. Cell Biol. 158: 563-575.
18. SCHWARTZBAUER, G. & J. ROBBINS. 2001. The tumor suppressor gene PTEN can regulate cardiac hypertrophy and survival. J. Biol. Chem. 276: 35786-35793.
19. MATSUI, T., J. TAO, F. DEL MONTE, et al. 2001. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 104: 330-335.
20. SHIOI, T., J.R. MCMULLEN, P.M. KANG, et al. 2002. Akt/protein kinase B promotes organ growth in transgenic mice. Mol. Cell. Biol. 22: 2799-2809.
21. MATSUI, T., L. LI, J.C. WU, et al. 2002. Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J. Biol. Chem. 277: 22896-22901.
22. CONDORELLI, G., A. DRUSCO, G. STASSI, et al. 2002. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc. Natl. Acad. Sci. USA 99: 12333-12338.
23. RYOKE, T., Y. GU, L. MAO, et al. 1999. Progressive cardiac dysfunction and fibrosis in the cardiomyopathic hamster and effects of growth hormone and angiotensin-converting enzyme inhibition. Circulation 100: 1734-1743.
24. DIEHL, J.A., M. CHENG, M.F. ROUSSEL & C.J. SHERR. 1998. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12: 3499-3511.
25. ANTOS, C.L., T.A. MCKINSEY, N. FREY, et al. 2002. Activated glycogen synthase-3beta suppresses cardiac hypertrophy in vivo. Proc. Natl. Acad. Sci. USA 99: 907-912.
26. SHIOI, T., J.R. MCMULLEN, O. TARNAVSKI, et al. 2003. Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation 107: 1664-1670.
27. KOVACIC, S., C.L. SOLTYS, A.J. BARR, et al. 2003. Akt activity negatively regulates phosphorylation of AMPK in the heart. J. Biol. Chem. 278: 39422-39427.
28. ROSS, J., JR. & M. HONGO. 1996. The role of hypertrophy and growth factors in heart failure. J. Card. Fail. 2: S121-S128.
29. NERI SERNERI, G.G., M. BODDI, P.A. MODESTI, et al. 2001. Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes. Circ. Res. 89: 977-982.
30. NERI SERNERI, G.G., P.A. MODESTI, M. BODDI, et al. 1999. Cardiac growth factors in human hypertrophy. Relations with myocardial contractility and wall stress. Circ. Res. 85: 57-67.
31. CITTADINI, A., H. STROMER, S.E. KATZ, et al. 1996. Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation. Circulation 93: 800-809.
32. REDAELLI, G., A. MALHOTRA, B. LI, et al. 1998. Effects of constitutive overexpression of insulin-like growth factor-1 on the mechanical characteristics and molecular properties of ventricular myocytes. Circ. Res. 82: 594-603.
33. WELCH, S., D. PLANK, S. WITT, et al. 2002. Cardiac-specific IGF-1 expression attenuates dilated cardiomyopathy in tropomodulin-overexpressing transgenic mice. Circ. Res. 90: 641-648.
34. DUERR, R.L., S. HUANG, H.R. MIRALIAKBAR, et al. 1995. Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J. Clin. Invest. 95: 619-627.
35. KIM, Y., S-J. KIM, A. YATANI, et al. 2003. Mechanism of enhanced cardiac function in mice with hypertrophy induced by overexpressed Akt. J. Biol. Chem. 278(48): 47622-47628.